This discord in pSMAD2 upregulation following SHP2 inhibition was similarly observed in the breast cancer cell lines MDA-MB-436 and BT474, suggesting that the SHP2 effect on TGFβ signalling is nuanced and likely influenced by multiple factors (Supplementary Fig. 3a–d). This evidence concerns the gene PTPN11 and breast cancer.